Tosiya Sato, Ph.D., Professor
Graduate students interested in the methods of biostatistics and the conduct of epidemiologic research and clinical trials are welcomed. This Department offers programs of study leading to a master’s degree and a doctoral degree. The Master of Public Health (MPH) degree program is designed to provide basic training in biostatistics as applied to a broad spectrum of health-related problems. The doctoral degree program is designed to provide advanced, research oriented training in methods of biostatistics.
Research and EducationMajor research fields are biostatistics methodology and conducts of epidemiologic studies and clinical trials. In methodological work, new epidemiologic study designs which are efficient and convenient are investigated for providing new sampling and analysis methods. Causal inference is the most challenging methodological research field. Estimation of causal parameters in experimental and observational studies is developing. Several collaborative studies in epidemiology and clinical trials are ongoing. Department of Biostatistics offers “Fundamentals of Biostatistics”, “Introduction to Statistical Computing and Data Management”, “Statistical Methods in Observational Studies”, “Intermediate Biostatistics”, and “Health Data Processing Laboratory”. We give introduction to concepts of randomization, causal effects, and confounding, designs of clinical trials and observational studies. Topics include randomization, experimentation, measurement, probability, confidence intervals, and tests of hypotheses.
Recent Publications1.Omasa M, Date H, Sozu T, Sato T, Nagai K, Yokoi K, Okamoto T, Ikeda N, Tanaka F, Maniwa Y, for the Japanese Association for Research on the Thymus. Postoperative radiotherapy is effective for thymic carcinoma but not for thymoma in stage II-III thymic epithelial tumors：the Japanese Association for Research on the Thymus Database Study. Cancer 2015; 121: 1008-1016.
2.Oba K, Sato T, Ogihara T, Saruta T, Nakao K. How to use marginal structural models in randomized trials to estimate the natural direct and indirect effects of therapies mediated by causal intermediates. Clinical Trials 2011; 8: 277-287.
3.Sozu T, Sugimoto T, Hamasaki T. Sample size determination in clinical trials with multiple co-primary binary endpoints. Statistics in Medicine 2010; 29: 2169-2179.
4.Chiba Y, Sato T, Greenland S. Bounds on potential risks and causal risk differences under assumptions of confounding parameters. Statistics in Medicine 2007; 26: 5125-5135.
5.Sato T, Matsuyama Y. Marginal structural models as a tool for standardization. Epidemiology 2003; 14: 680-686.
BiostatisticsProfessor Tosiya Sato, Ph.D.
Secretary Hiroko Kobayashi